AbCellera Biologics Inc.ABCLNASDAQ
Loading
ROE: Returns DecliningContracting
Percentile Rank29
Studio
Year-over-Year Change

Return on equity

Percentile
P29
Within normal range
vs 5Y Ago
-0.9x
Contraction
Streak
1 yr
Consecutive growthContracting
PeriodValueYoY Change
2025-12.83%+16.8%
2024-15.42%-21.4%
2023-12.70%-198.8%
202212.85%-14.1%
202114.96%+4.5%
202014.32%+166.4%
2019-21.57%-910.3%
20182.66%-